Early research (Phase 1)Study completedNCT00869895What this trial is testingA Dose-Finding Study of E7050 Administered Orally to Patients With Advanced Solid TumorsWho this might be right forCancer Eisai Inc. 60
Not applicableStudy completedNCT06231537What this trial is testingVisual Oral Examination for Early Detection of Oral Cancer in High-Risk IndividualsWho this might be right forMouth Neoplasms Universidade Federal do Rio de Janeiro 1,152
Early research (Phase 1)Ended earlyNCT03816839What this trial is testingEvaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)Who this might be right forBreast Cancer Sanofi 10
Testing effectiveness (Phase 2)Study completedNCT01532700What this trial is testingAn Open-Label Phase 2 Study of Ofatumumab (Arzerra) in Combination With Oral GSK2110183 in the Treatment of Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia (CLL) University Health Network, Toronto 28
Large-scale testing (Phase 3)UnknownNCT00002653What this trial is testingCombination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Medical Research Council 1,000
Early research (Phase 1)Study completedNCT02171637What this trial is testingDose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid TumorsWho this might be right forNeoplasms Boehringer Ingelheim 38
Testing effectiveness (Phase 2)Study completedNCT00076102What this trial is testingPirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform NeurofibromasWho this might be right forNeurofibromatosis 1Neurofibroma, Plexiform National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Ended earlyNCT01011439What this trial is testingPhase II Study Of Oral PHA-848125AC In Patients With Thymic CarcinomaWho this might be right forThymic Carcinoma Tiziana Life Sciences LTD 72
Not applicableStudy completedNCT06730139What this trial is testingOral Health Related Quality of Life in Head and Neck Cancer Survivors Within the First Year Following TreatmentWho this might be right forHead and Neck Cancer Ain Shams University 120
Large-scale testing (Phase 3)Study completedNCT00964977What this trial is testingEffectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metastasis.Who this might be right forOropharyngeal CancerOral CancerLymph Node Metastasis Johannes Gutenberg University Mainz 209
Early research (Phase 1)Study completedNCT02063230What this trial is testingTo Assess the Pharmacokinetics, Safety and Tolerability of Selumetinib in Patients With Hepatic Impairment and Healthy SubjectsWho this might be right forSolid Tumors AstraZeneca 32
Testing effectiveness (Phase 2)Study completedNCT00003565What this trial is testingDocetaxel in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerHead and Neck Cancer+2 more Alliance for Clinical Trials in Oncology 109
Early research (Phase 1)Looking for participantsNCT05367700What this trial is testingHS-10382 in Patients With Chronic Myeloid Leukemia.Who this might be right forCML, Chronic PhaseCML, Accelerated Phase Jiangsu Hansoh Pharmaceutical Co., Ltd. 108
Early research (Phase 1)UnknownNCT04122339What this trial is testingMAX-10181 Given Orally to Patients With Advanced Solid TumorWho this might be right forSolid Tumor Maxinovel Pty., Ltd. 30
Early research (Phase 1)Study completedNCT00003430What this trial is testingL-778,123 in Treating Patients With Recurrent or Refractory Solid TumorsWho this might be right forHead and Neck CancerUnspecified Adult Solid Tumor, Protocol Specific Memorial Sloan Kettering Cancer Center 40
Testing effectiveness (Phase 2)UnknownNCT04813107What this trial is testingEvaluate the Safety and Efficacy of Oral APL-1202 in Combination With Tislelizumab Compared to Tislelizumab Alone as Neoadjuvant Therapy in Patients With Muscle Invasive Bladder CancerWho this might be right forMuscle Invasive Bladder Cancer Jiangsu Yahong Meditech Co., Ltd aka Asieris 79
Not applicableLooking for participantsNCT05554133What this trial is testingPrecision Optical Guidance for Oral BiopsyWho this might be right forOral Lesions M.D. Anderson Cancer Center 90
Testing effectiveness (Phase 2)Study completedNCT01941992What this trial is testingRole of SAMITAL® in the Relief of Chemo-radiation (CT-RT) Induced Oral Mucositis in Head and Neck Cancer PatientsWho this might be right forHead-and-neck Squamous Cell CarcinomaOral Mucositis Istituto Oncologico Veneto IRCCS 120
Early research (Phase 1)Study completedNCT01061411What this trial is testingDalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryWho this might be right forClear Cell Sarcoma of the KidneyRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer+1 more Roswell Park Cancer Institute 16
Testing effectiveness (Phase 2)Study completedNCT00052611What this trial is testingCelecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck DysplasiaWho this might be right forHead and Neck Cancer Dana-Farber Cancer Institute 23